- Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells
-
Choi BH, Chakraborty G, Baek K, Yoon HS
- KMID: 2154266
- Exp Mol Med.
- 2013 Oct;45(10):e47.
Here, we report that B-cell lymphoma 2 (Bcl-2) is a novel target molecule of aspirin in breast cancer cells. Aspirin influenced the formation of a complex by Bcl-2 and FKBP38... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer cell metabolism: implications for therapeutic targets
-
Jang M, Kim SS, Lee J
- KMID: 2154264
- Exp Mol Med.
- 2013 Oct;45(10):e45.
Cancer cell metabolism is characterized by an enhanced uptake and utilization of glucose, a phenomenon known as the Warburg effect. The persistent activation of aerobic glycolysis in cancer cells can... -
- CITED
-
- Close
- SHARE
-
- Close
- Discriminant analysis of prion sequences for prediction of susceptibility
-
Lee JH, Bae SE, Jung S, Ahn I, Son HS
- KMID: 2154267
- Exp Mol Med.
- 2013 Oct;45(10):e48.
Prion diseases, including ovine scrapie, bovine spongiform encephalopathy (BSE), human kuru and Creutzfeldt-Jakob disease (CJD), originate from a conformational change of the normal cellular prion protein (PrPC) into abnormal protease-resistant... -
- CITED
-
- Close
- SHARE
-
- Close
- In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis
-
Moon SJ, Park JS, Heo YJ, Kang CM, Kim EK, Lim MA, Ryu JG, Park SJ, Park KS, Sung YC, Park SH, Kim HY, Min JK, Cho ML
- KMID: 2154265
- Exp Mol Med.
- 2013 Oct;45(10):e46.
Interleukin (IL)-27 is a novel cytokine of the IL-6/IL-12 family that has been reported to be involved in the pathogenesis of autoimmune diseases and has a pivotal role as both... -
- CITED
-
- Close
- SHARE
-
- Close
- Targeted resequencing of candidate genes reveals novel variants associated with severe Behcet's uveitis
-
Kim SJ, Lee S, Park C, Seo JS, Kim JI, Yu HG
- KMID: 2154268
- Exp Mol Med.
- 2013 Oct;45(10):e49.
Behcet's disease (BD) is a chronic systemic inflammatory disorder characterized by four major manifestations: recurrent uveitis, oral and genital ulcers and skin lesions. To identify some pathogenic variants associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination treatment with 2-methoxyestradiol overcomes bortezomib resistance of multiple myeloma cells
-
Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Lee SR, Ko TH, Youm JB, Kim N, Ko KS, Rhee BD, Han J
- KMID: 2154269
- Exp Mol Med.
- 2013 Oct;45(10):e50.
Bortezomib is a proteasome inhibitor used for the treatment of relapsed/refractory multiple myeloma (MM). However, intrinsic and acquired resistance to bortezomib has already been observed in MM patients. In a... -
- CITED
-
- Close
- SHARE
-
- Close
